Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0
Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0
Active, not recruiting · NCT04045717 · Registry updated 2023-12-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0 | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate adenocarcinoma, prostate cancer, prostate disorder | Active, not recruiting | Phase 2 | 2023-12-01 | NCT04045717 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kom Op Tegen Kanker | 20 |
| Radboud University Medical Center | 216 |
| The Netherlands Cancer Institute | 113 |
| Universitaire Ziekenhuizen KU Leuven | 262 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Radboudumc | Nijmegen | Netherlands | 24 |
| The Netherlands Cancer Institute | Amsterdam | Netherlands | 5 |
| University Hospitals Leuven | Leuven | Belgium | 32 |